216080.KQ
JETEMA, Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 6,420.00
+3.88%Year over year
Reported trailing growth
- Revenue
- +8.8%
- EBITDA
- -5.5%
- EBIT
- +106.1%
- EPS
- +69.5%
- Free cash flow
- -52.4%
- Operating cash flow
- -23.4%
Forward estimates
Based on analyst estimates
- Revenue
- -18.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +18.7%
- EBITDA
- -9.9%
- EBIT
- -1.6%
- Net income
- —
- EPS
- —
- Free cash flow
- +206.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026